Dr. Matthew Campbell, MD
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Area of expertise
Bladder Cancer
Matthew Campbell, MD has run 5 trials for Bladder Cancer. Some of their research focus areas include:
Rhabdomyosarcoma
Matthew Campbell, MD has run 5 trials for Rhabdomyosarcoma. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
UT Southwestern/Simmons Cancer Center-Dallas
Clinical Trials Matthew Campbell, MD is currently running
Digoxin
for Medulloblastoma
The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Recruiting
1 award
Phase 2
9 criteria
NK Cells + Chemotherapy
for Sarcoma
The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with childhood sarcomas that have relapsed or not responded to prior therapies. The goals of this study are: * To determine the safety and efficacy of the addition of adoptive transfer of universal donor, TGFβ imprinted (TGFβi), expanded NK cells to the pediatric sarcoma salvage chemotherapeutic regimen gemcitabine/docetaxel (GEM/DOX) for treatment of relapsed and refractory pediatric sarcomas To determine the 6-month progression free survival achieved with this treatment in patients within cohorts of relapsed or refractory osteosarcoma, Ewing sarcoma, rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma. * To identify toxicities related to treatment with GEM/DOX + TGFβi expanded NK cells Participants will receive study drugs that include chemotherapy and NK cells in cycles; each cycle is 21 days long and you can receive up to 8 cycles. * Gemcitabine (GEM): via IV on Days 1 and 8 * Docetaxel (DOX): via IV on Day 8 * Prophylactic dexamethasone: Day 7-9 to prevent fluid retention and hypersensitivity reaction * Peg-filgrastim (PEG-GCSF) or biosimilar: Day 9 to help your white blood cell recover and allow more chemotherapy to be given * TGFβi NK cells: via IV on Day 12
Recruiting
1 award
Phase 1 & 2
More about Matthew Campbell, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Matthew Campbell, MD has experience with
- Cyclophosphamide
- Dactinomycin
- Cisplatin
- Doxorubicin Hydrochloride
- Methotrexate
- Cabozantinib
Breakdown of trials Matthew Campbell, MD has run
Bladder Cancer
Rhabdomyosarcoma
Bone Cancer Survivors
Embryonal Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Campbell, MD specialize in?
Matthew Campbell, MD focuses on Bladder Cancer and Rhabdomyosarcoma. In particular, much of their work with Bladder Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Matthew Campbell, MD currently recruiting for clinical trials?
Yes, Matthew Campbell, MD is currently recruiting for 5 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Matthew Campbell, MD has studied deeply?
Yes, Matthew Campbell, MD has studied treatments such as Cyclophosphamide, Dactinomycin, Cisplatin.
What is the best way to schedule an appointment with Matthew Campbell, MD?
Apply for one of the trials that Matthew Campbell, MD is conducting.
What is the office address of Matthew Campbell, MD?
The office of Matthew Campbell, MD is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.